Integra Lifesciences Holdings (IART) Raw Materials (2010 - 2017)
Integra Lifesciences Holdings (IART) reported Raw Materials of $48.4 million for Q3 2017, up 23.2% sequentially from $39.2 million in Q4 2016.
Integra Lifesciences Holdings (IART) Raw Materials (2010 - 2017) Analysis & Trends
Integra Lifesciences Holdings (IART) has 7 years of Raw Materials data on file, last reported at $48.4 million in Q3 2017.
- For the quarter ending Q3 2017, Raw Materials changed N/A year-over-year to $48.4 million; the trailing twelve-month figure through Sep 2017 stood at $48.4 million (changed N/A YoY), and the FY2016 full-year result was $39.2 million, changed N/A from the prior year.
- Raw Materials climbed to $48.4 million in Q3 2017, from $39.2 million in the prior quarter.
- In the past five years, Raw Materials ranged from a high of $48.4 million in Q3 2017 to a low of $36.5 million in Q4 2014.
- A 4-year average of $41.1 million and a median of $39.7 million in 2015 frame the typical range for Raw Materials.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.67 Bn | 176.38 Bn | 6.27 Bn |
| 2 | Stryker | 128.91 Bn | 126.03 Bn | 3.81 Bn |
| 3 | Medtronic | 108.84 Bn | 99.62 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.68 Bn | 45.01 Bn | 1.29 Bn |
| 6 | Dexcom | 28.42 Bn | 27.31 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.38 Bn | 26.09 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.94 Bn | 26.36 Bn | - |
| 9 | Koninklijke Philips | 25.50 Bn | 22.38 Bn | 2.07 Bn |
| 10 | Integra Lifesciences Holdings | 1.53 Bn | 1.26 Bn | 216.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | 48.35 Mn |
| Dec 31, 2016 | 39.25 Mn |
| Jun 30, 2015 | 40.22 Mn |
| Dec 31, 2014 | 36.47 Mn |
| Jun 30, 2012 | 28.40 Mn |
| Mar 31, 2012 | 27.23 Mn |
| Dec 31, 2011 | 28.22 Mn |
| Sep 30, 2011 | 29.69 Mn |
| Jun 30, 2011 | 29.95 Mn |
| Dec 31, 2010 | 27.88 Mn |